LISATA THERAPEUTICS, INC. Retained Earnings
LISATA THERAPEUTICS, INC. (LSTA) had Retained Earnings of -$572.07 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$572.07M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$569.14M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$564.65M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$561.70M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$572.07M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$569.14M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | -$564.65M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$561.70M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$557.45M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$552.79M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$548.07M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$543.46M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$538.53M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$533.48M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$528.08M 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$522.72M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | -$517.46M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$513.43M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | -$507.24M 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$501.25M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$463.87M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$457.24M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$453.02M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$446.22M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$439.30M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$433.61M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$425.55M 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$420.12M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$414.79M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$421.39M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$417.40M 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$412.44M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | -$407.55M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$402.41M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$397.98M 10-K · filed 2020-03-05 | |
| 2018-09-30 | -$394.42M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$390.87M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$386.79M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$381.81M 10-K · filed 2019-03-14 | -$381.81M 10-K · filed 2018-03-22 |
| 2017-09-30 | -$378.95M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$375.43M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$414.15M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$404.79M 10-K · filed 2018-03-22 | |
| 2016-09-30 | -$398.83M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$391.95M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$384.11M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$372.13M 10-K · filed 2017-03-17 | |
| 2015-09-30 | -$338.94M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$327.56M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$310.43M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$291.25M 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$279.63M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | -$262.66M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$250.06M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$236.37M 10-K · filed 2015-03-02 | |
| 2013-09-30 | -$223.84M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$214.77M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$206.19M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$197.39M 10-K · filed 2014-03-13 | |
| 2012-09-30 | -$181.62M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$173.14M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$152.55M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$143.09M 10-K · filed 2013-03-11 | |
| 2011-09-30 | -$124.12M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | -$116.46M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | -$95.32M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |